Cargando…
Modeling Alzheimer’s disease in transgenic rats
Alzheimer’s disease (AD) is the most common form of dementia. At the diagnostic stage, the AD brain is characterized by the accumulation of extracellular amyloid plaques, intracellular neurofibrillary tangles and neuronal loss. Despite the large variety of therapeutic approaches, this condition rema...
Autores principales: | Do Carmo, Sonia, Cuello, A Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231465/ https://www.ncbi.nlm.nih.gov/pubmed/24161192 http://dx.doi.org/10.1186/1750-1326-8-37 |
Ejemplares similares
-
Experimental Pharmacology in Transgenic Rodent Models of Alzheimer’s Disease
por: Cuello, A. Claudio, et al.
Publicado: (2019) -
Longitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer's disease
por: Galeano, Pablo, et al.
Publicado: (2014) -
The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer’s Cholinergic Atrophy
por: Do Carmo, Sonia, et al.
Publicado: (2021) -
Neuropathological changes and cognitive deficits in rats transgenic for human mutant tau recapitulate human tauopathy
por: Malcolm, Janice C., et al.
Publicado: (2019) -
Modeling Alzheimer's disease with non-transgenic rat models
por: Lecanu, Laurent, et al.
Publicado: (2013)